Sucralose in Subjects With Diabetes Mellitus Insulin Requesting
NCT ID: NCT02813759
Last Updated: 2016-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2015-07-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Sucralose on Glucose Metabolism
NCT02589002
Formulas for Diabetes With Sucromalt & Isomaltulose on Glycemic Index, Hormones & Subjective Appetite in Type 2 Diabetes
NCT03829800
Metabolic Response of Slow Released Carbohydrates in Diabetes Mellitus
NCT01070238
Effects of Artificial Sweeteners on Glucose Metabolism in Patients With Type 2 Diabetes
NCT04185662
Glycemic and Insulinemic Response With Different Sources of Soluble Fiber in Patients Type 2 Diabetes Mellitus
NCT02204384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sucralose
14 mg sucralose (Zero K sucralose powder, IANSA®) an 200 mL of water
Sucralose
Subjects drank 200 mL of water with 14 mg sucralose, followed by a standard breakfast.
Water
200 mL of water
Placebo
Subjects drank 200 mL of water alone (placebo), followed by a standard breakfast.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sucralose
Subjects drank 200 mL of water with 14 mg sucralose, followed by a standard breakfast.
Placebo
Subjects drank 200 mL of water alone (placebo), followed by a standard breakfast.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prescription rapid insulin in the breakfast
* Aged 35 to 70 years
* BMI 25 to 39.9 kg / m2
* HbA1c lower than or equal to 10% (86 mmol / mol)
* Menopausal women under hormone replacement therapy
Exclusion Criteria
* Pregnant women
* Puerperal women
* Subjects with neurological disease, endocrine disorder no treatment, kidney disease stage IV or V, cancer, liver disease, chronic obstructive pulmonary disease, HIV
* Subjects with history of stroke , acute myocardial infarction and gastrointestinal resection
35 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Valparaiso
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudia Vega Soto
Nutritionist
References
Explore related publications, articles, or registry entries linked to this study.
Lohner S, Kuellenberg de Gaudry D, Toews I, Ferenci T, Meerpohl JJ. Non-nutritive sweeteners for diabetes mellitus. Cochrane Database Syst Rev. 2020 May 25;5(5):CD012885. doi: 10.1002/14651858.CD012885.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.